187 related articles for article (PubMed ID: 15148155)
1. Narcolepsy caused by acute disseminated encephalomyelitis.
Gledhill RF; Bartel PR; Yoshida Y; Nishino S; Scammell TE
Arch Neurol; 2004 May; 61(5):758-60. PubMed ID: 15148155
[TBL] [Abstract][Full Text] [Related]
2. Hypersomnia and low cerebrospinal fluid hypocretin levels in acute disseminated encephalomyelitis.
Yoshikawa S; Suzuki S; Kanbayashi T; Nishino S; Tamai H
Pediatr Neurol; 2004 Nov; 31(5):367-70. PubMed ID: 15519122
[TBL] [Abstract][Full Text] [Related]
3. Decreased cerebrospinal fluid hypocretin-1 levels near the onset of narcolepsy in 2 prepubertal children.
Kubota H; Kanbayashi T; Tanabe Y; Ito M; Takanashi J; Kohno Y; Shimizu T
Sleep; 2003 Aug; 26(5):555-7. PubMed ID: 12938807
[TBL] [Abstract][Full Text] [Related]
4. Decreased hypocretin-1 (Orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness.
Martínez-Rodríguez JE; Lin L; Iranzo A; Genis D; Martí MJ; Santamaria J; Mignot E
Sleep; 2003 May; 26(3):287-90. PubMed ID: 12749547
[TBL] [Abstract][Full Text] [Related]
5. The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A).
Bassetti C; Gugger M; Bischof M; Mathis J; Sturzenegger C; Werth E; Radanov B; Ripley B; Nishino S; Mignot E
Sleep Med; 2003 Jan; 4(1):7-12. PubMed ID: 14592354
[TBL] [Abstract][Full Text] [Related]
6. Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy.
Andlauer O; Moore H; Hong SC; Dauvilliers Y; Kanbayashi T; Nishino S; Han F; Silber MH; Rico T; Einen M; Kornum BR; Jennum P; Knudsen S; Nevsimalova S; Poli F; Plazzi G; Mignot E
Sleep; 2012 Sep; 35(9):1247-55F. PubMed ID: 22942503
[TBL] [Abstract][Full Text] [Related]
7. A case of acute disseminated encephalomyelitis presenting hypersomnia with decreased hypocretin level in cerebrospinal fluid.
Kubota H; Kanbayashi T; Tanabe Y; Takanashi J; Kohno Y
J Child Neurol; 2002 Jul; 17(7):537-9. PubMed ID: 12269735
[TBL] [Abstract][Full Text] [Related]
8. Hypocretin (orexin) deficiency in narcolepsy and primary hypersomnia.
Ebrahim IO; Sharief MK; de Lacy S; Semra YK; Howard RS; Kopelman MD; Williams AJ
J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):127-30. PubMed ID: 12486284
[TBL] [Abstract][Full Text] [Related]
9. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
Nishino S; Kanbayashi T
Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
[TBL] [Abstract][Full Text] [Related]
10. Rasmussen's syndrome and new-onset narcolepsy, cataplexy, and epilepsy in an adult.
Lagrange AH; Blaivas M; Gomez-Hassan D; Malow BA
Epilepsy Behav; 2003 Dec; 4(6):788-92. PubMed ID: 14698722
[TBL] [Abstract][Full Text] [Related]
11. CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia.
Kanbayashi T; Inoue Y; Chiba S; Aizawa R; Saito Y; Tsukamoto H; Fujii Y; Nishino S; Shimizu T
J Sleep Res; 2002 Mar; 11(1):91-3. PubMed ID: 11869432
[TBL] [Abstract][Full Text] [Related]
12. The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions.
Zeitzer JM; Nishino S; Mignot E
Trends Pharmacol Sci; 2006 Jul; 27(7):368-74. PubMed ID: 16766052
[TBL] [Abstract][Full Text] [Related]
13. Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency.
Knudsen S; Gammeltoft S; Jennum PJ
Brain; 2010 Feb; 133(Pt 2):568-79. PubMed ID: 20129934
[TBL] [Abstract][Full Text] [Related]
14. Degenerative pontine lesions in patients with familial narcolepsy.
Stepień A; Staszewski J; Domzał TM; Tomczykiewicz K; Skrobowska E; Durka-Kesy M
Neurol Neurochir Pol; 2010; 44(1):21-7. PubMed ID: 20358482
[TBL] [Abstract][Full Text] [Related]
15. [Moebius syndrome and narcolepsy].
Krämer S; Goldammer U; Sindern E
Nervenarzt; 2014 Dec; 85(12):1569-72. PubMed ID: 25388761
[TBL] [Abstract][Full Text] [Related]
16. Monozygotic twins concordant for narcolepsy-cataplexy without any detectable abnormality in the hypocretin (orexin) pathway.
Khatami R; Maret S; Werth E; Rétey J; Schmid D; Maly F; Tafti M; Bassetti CL
Lancet; 2004 Apr; 363(9416):1199-200. PubMed ID: 15081654
[TBL] [Abstract][Full Text] [Related]
17. Report of a case of immunosuppression with prednisone in an 8-year-old boy with an acute onset of hypocretin-deficiency narcolepsy.
Hecht M; Lin L; Kushida CA; Umetsu DT; Taheri S; Einen M; Mignot E
Sleep; 2003 Nov; 26(7):809-10. PubMed ID: 14655912
[TBL] [Abstract][Full Text] [Related]
18. Hypocretin/orexin and sleep: implications for the pathophysiology and diagnosis of narcolepsy.
Overeem S; Scammell TE; Lammers GJ
Curr Opin Neurol; 2002 Dec; 15(6):739-45. PubMed ID: 12447114
[TBL] [Abstract][Full Text] [Related]
19. [Narcolepsy-cataplexy].
Deflandre E; Roelants F; Cambron L; Poirrier R
Rev Med Liege; 2002 Aug; 57(8):519-27. PubMed ID: 12405025
[TBL] [Abstract][Full Text] [Related]
20. [Excessive daytime sleepiness and low CSF orexin-A/hypocretin-I levels in a patient with probable progressive supranuclear palsy].
Hattori Y; Hattori T; Mukai E; Mori H; Mizuno Y; Kayukawa Y; Okada T; Kanbayashi T
No To Shinkei; 2003 Dec; 55(12):1053-6. PubMed ID: 14870576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
